[Multifactorial primary prevention trials in ischemic heart disease].

Area of Science:

• Cardiovascular disease prevention
• Public health research
• Epidemiology

Background:

• Cardiovascular diseases remain a major global health concern.
• Primary prevention trials are crucial for understanding risk reduction.
• Identifying effective interventions for high-risk populations is essential.

Purpose of the Study:

• To evaluate the effectiveness of multifactorial interventions in reducing cardiovascular disease.
• To determine the relationship between risk factor reduction and disease incidence.
• To assess the impact of personalized versus collective intervention strategies.

Main Methods:

• Analysis of two randomized multifactorial primary preventive trials (Oslo, MRFIT) with personalized interventions.
• Review of the World Health Organization (WHO) cooperative trial with collective intervention.
• Examination of a 10-year community program in North Karelia.
• Quantitative assessment of risk factor reduction and disease frequency.

Main Results:

• Multifactorial risk was reduced in both Oslo and MRFIT trials.
• Serum cholesterol levels showed significant differences in the Oslo trial, correlating with lowered severe case incidence.
• Reduced incidence or mortality was observed in national projects only when both multifactorial risk and serum cholesterol were lowered.
• The North Karelia community program demonstrated decreased risk factor levels and mortality.

Conclusions:

• A consistent quantitative relationship exists between multifactorial risk reduction, serum cholesterol decrease, and disease frequency.
• Multifactorial interventions, particularly those lowering serum cholesterol, are effective in primary cardiovascular prevention.
• Cardiovascular disease prevention is a critical public health challenge requiring effective strategies.